Skip to main content Accessibility help
×
Home

Authors’ reply

  • Mourad Wahba (a1), Soraia Sousa (a2), Stuart Watson (a3), Rebecca Strawbridge (a4), Allan H. Young (a5) and Anne Lingford-Hughes (a6)...
  • In response to commentaries on:

Copyright

References

Hide All
1Clare, CE, Brassington, AH, Kwong, WY, Sinclair, KD. One-carbon metabolism: linking nutritional biochemistry to epigenetic programming of long-term development. Annu Rev Anim Biosci 2019; 7: 263–87.
2Ducker, G, Rabinowitz, J. One-carbon metabolism in health and disease. Cell Metabolism 2017; 25: 2742.
3Lewis, S, Lawlor, D, Davey Smith, G, Araya, R, Timpson, N, Day, IN, et al. The thermolabile variant of MTHFR is associated with depression in the British Women's Heart and Health Study and a meta-analysis. Mol Psychiatry 2006; 11: 352–60.
4Jiang, W, Xu, J, Lu, X, Sun, Y. Association between MTHFR C677T polymorphism and depression: a meta-analysis in the Chinese population. Psychol Health Med 2015; 21: 675–85.
5Wu, YL, Ding, XX, Sun, YH, Yang, HY, Chen, J, Zhao, X, et al. Association between MTHFR C677T polymorphism and depression: an updated meta-analysis of 26 studies. Prog Neuro-Psychopharmacol Biol Psychiatry 2013; 46: 7885.
6Cho, K, Amin, ZM, An, J, Rambaran, KA, Johnson, TB, Alzghari, SK. Methylenetetrahydrofolate reducatese A1298C polymorphism and major depressive disorder. Cureus 2017; 9: e1734.
7Frankenburg, FR. The role of one-carbon metabolism in schizophrenia and depression. Harv Rev Psychiatry 2007; 15: 146–60.
8Reynolds, EH. Folic acid, ageing, depression, and dementia. BMJ 2002; 324: 1512–5.
9Bottiglieri, T, Laundy, M, Crellin, R, Toone, B, Carney, MWP, Reynolds, EH. Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry 2000; 69: 228–32.
10Scheft, C, Kilarski, LL, Bschor, T, Kohler, S. Efficacy of adding nutritional supplements in unipolar depression: a systematic review and meta-analysis. Eur Neuropsychopharmacol 2017; 27: 1090–109.
11Sarris, J, Murphy, J, Mischoulon, D, Papakostas, GI, Fava, M, Berk, M, et al. Adjunctive nutraceuticals for depression: a systematic review and meta-analysis. Am J Psychiatry 2016; 173: 575–87.
12Papakostas, GI, Shelton, RC, Zajecka, JM, Etemad, B, Rickels, K, Clain, A, et al. L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials. Am J Psychiatry 2012; 169: 1267–74.
13Reynold, EH, Crellin, R, Bottiglieri, T, Laundy, M, Toone, BK, Carney, MWP. Methylfolate as monotherapy in depression. A pilot randomised controlled trial. J Neurol Psychol 2015; 3: 59.
14Strawbridge, R, Carter, B, Marwood, L, Bandelow, B, Tsapekos, D, Nikolova, VL, et al. Augmentation therapies for treatment-resistant depression: a systematic review and meta-analysis. Br J Psychiatry 2019; 214: 4251.
15Scott, F, Strawbridge, R, Marwood, L, Gnanapragasam, S, Bandelow, B, Cleare, A, Young, AH. Systematic review and meta-analysis of the efficacy of psychological and pharmacological combination and augmentation treatments for treatment-resistant depression. 2018, Prospero register CRD42018117366. Available at: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=117366

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Authors’ reply

  • Mourad Wahba (a1), Soraia Sousa (a2), Stuart Watson (a3), Rebecca Strawbridge (a4), Allan H. Young (a5) and Anne Lingford-Hughes (a6)...
  • In response to commentaries on:
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *